Clinical Trial Update: Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)

View source ↗

Summary

A pilot clinical study (THROPIQ) is evaluating whether thrombomodulin can help rule out giant cell arteritis in patients with polymyalgia rheumatica, and the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Polymyalgia Rheumatica

Drugs mentioned

• Thrombomodulin (recombinant human thrombomodulin)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR) | Status: RECRUITING